Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002778535 | SCV003591657 | uncertain significance | Inborn genetic diseases | 2021-11-30 | criteria provided, single submitter | clinical testing | The c.5008A>G (p.I1670V) alteration is located in exon 31 (coding exon 31) of the NBEA gene. This alteration results from a A to G substitution at nucleotide position 5008, causing the isoleucine (I) at amino acid position 1670 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV003135237 | SCV003813466 | uncertain significance | Neurodevelopmental disorder with or without early-onset generalized epilepsy | 2019-11-07 | criteria provided, single submitter | clinical testing |